SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001615774-19-003014
Filing Date
2019-02-26
Accepted
2019-02-26 13:22:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A s116340_sc13ga.htm SC 13G/A 49430
  Complete submission text file 0001615774-19-003014.txt   50935
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Subject) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87828 | Film No.: 19632722
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901
Business Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901 908-897-0513
ETF MANAGERS GROUP, LLC (Filed by) CIK: 0001645173 (see all company filings)

IRS No.: 383938178 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A